OTR Acquisition Corp.

No Longer Reporting

The company has not filed an annual or quarterly report since its Q1 FY2022 10-Q, filed May 13, 2022. Its latest SEC filing is a SC 13G/A from Feb 13, 2023.

The sections below describe the company as of the FY2020 annual report.

What Did They Do?

Seeks to combine with one or more businesses through a merger, acquisition or similar transaction, with potential targets in any industry or region.

How Did They Make Money?

No revenue was reported.

How Were They Changing?

Since the FY2020 annual report

Latest quarter: Q1 FY2022, the three months to Mar 31, 2022

Net income: ▼ −57%; vs $4.2M in Q1 FY2021

May 24, 2022 Completed business combination with Comera Comera became a publicly traded company, and OTR became a wholly owned subsidiary of Holdco.

Financial Snapshot

Last updated: 10/23/2026

Size

Revenue: N/A
Net Income: N/A

Growth

Revenue Growth: N/A
EPS Growth: N/A

Profitability

Gross Margin: N/A
Operating Margin: N/A
Net Income Margin: N/A

Cash flow

Free Cash Flow: N/A

Balance sheet

Cash: N/A
Debt to Equity: N/A

Valuation

Market Cap: N/A
P/E: N/A

Company Facts

Industry: Pharmaceutical Preparations
Incorporated
Headquarters

Comments